Our results indicated that BASP1 was associated with immune cell infiltration and ferroptosis in HNSCC and could predict prognosis and anti-PD-1 therapeutic response, which might offer a novel therapeutic strategy for HNSCC patients. Here, PDCD1 is linked to head and neck squamous cell carcinoma.